Traf3ip2 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1312403 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRAF3IP2 mRNA CTD PMID:22079256 Traf3ip2 Rat 17beta-estradiol increases expression ISO RGD:1312404 6480464 Estradiol results in increased expression of TRAF3IP2 mRNA CTD PMID:39298647 Traf3ip2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TRAF3IP2 mRNA CTD PMID:22298810 Traf3ip2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TRAF3IP2 mRNA CTD PMID:33387578 Traf3ip2 Rat 2-butoxyethanol decreases expression ISO RGD:1312404 6480464 n-butoxyethanol results in decreased expression of TRAF3IP2 mRNA CTD PMID:19812364 Traf3ip2 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:1312404 6480464 bisphenol S results in increased expression of TRAF3IP2 mRNA CTD PMID:30951980|PMID:39298647 Traf3ip2 Rat 4-hydroxynon-2-enal decreases expression ISO RGD:1312404 6480464 4-hydroxy-2-nonenal results in decreased expression of TRAF3IP2 mRNA CTD PMID:19191707 Traf3ip2 Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:1312404 6480464 Fenretinide results in increased expression of TRAF3IP2 mRNA CTD PMID:28973697 Traf3ip2 Rat 5-aza-2'-deoxycytidine affects expression ISO RGD:1312403 6480464 Decitabine affects the expression of TRAF3IP2 mRNA CTD PMID:23300844 Traf3ip2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of TRAF3IP2 mRNA CTD PMID:24780913 Traf3ip2 Rat 6-propyl-2-thiouracil multiple interactions ISO RGD:1312404 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRAF3IP2 mRNA CTD PMID:36706583 Traf3ip2 Rat acrolein multiple interactions ISO RGD:1312403 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Traf3ip2 Rat aflatoxin B1 increases methylation ISO RGD:1312403 6480464 Aflatoxin B1 results in increased methylation of TRAF3IP2 gene CTD PMID:27153756 Traf3ip2 Rat all-trans-retinoic acid increases expression ISO RGD:1312403 6480464 Tretinoin results in increased expression of TRAF3IP2 mRNA CTD PMID:33167477 Traf3ip2 Rat alpha-pinene multiple interactions ISO RGD:1312403 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Traf3ip2 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of TRAF3IP2 mRNA CTD PMID:30779732 Traf3ip2 Rat antirheumatic drug decreases expression ISO RGD:1312403 6480464 Antirheumatic Agents results in decreased expression of TRAF3IP2 mRNA CTD PMID:24449571 Traf3ip2 Rat arsane multiple interactions ISO RGD:1312403 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRAF3IP2 more ... CTD PMID:39836092 Traf3ip2 Rat arsenic atom multiple interactions ISO RGD:1312403 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRAF3IP2 more ... CTD PMID:39836092 Traf3ip2 Rat arsenous acid increases expression ISO RGD:1312403 6480464 Arsenic Trioxide results in increased expression of TRAF3IP2 mRNA CTD PMID:15761015 Traf3ip2 Rat azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 Traf3ip2 Rat benzo[a]pyrene increases methylation ISO RGD:1312403 6480464 Benzo(a)pyrene results in increased methylation of TRAF3IP2 promoter CTD PMID:27901495 Traf3ip2 Rat benzo[a]pyrene decreases methylation ISO RGD:1312403 6480464 Benzo(a)pyrene results in decreased methylation of TRAF3IP2 3' UTR CTD PMID:27901495 Traf3ip2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TRAF3IP2 mRNA CTD PMID:25181051 Traf3ip2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TRAF3IP2 mRNA CTD PMID:35192832 Traf3ip2 Rat bisphenol A increases expression ISO RGD:1312404 6480464 bisphenol A results in increased expression of TRAF3IP2 mRNA CTD PMID:30951980 Traf3ip2 Rat bisphenol F increases expression ISO RGD:1312404 6480464 bisphenol F results in increased expression of TRAF3IP2 mRNA CTD PMID:30951980 Traf3ip2 Rat bleomycin A2 multiple interactions ISO RGD:1312404 6480464 Calcitriol inhibits the reaction [Bleomycin results in increased phosphorylation of ACT1 protein] CTD PMID:26520185 Traf3ip2 Rat cadmium dichloride decreases expression ISO RGD:1312403 6480464 Cadmium Chloride results in decreased expression of TRAF3IP2 mRNA CTD PMID:38568856 Traf3ip2 Rat calcitriol multiple interactions ISO RGD:1312404 6480464 Calcitriol inhibits the reaction [Bleomycin results in increased phosphorylation of ACT1 protein] CTD PMID:26520185 Traf3ip2 Rat CGP 52608 multiple interactions ISO RGD:1312403 6480464 CGP 52608 promotes the reaction [RORA protein binds to TRAF3IP2 gene] CTD PMID:28238834 Traf3ip2 Rat chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 Traf3ip2 Rat chlorpyrifos decreases expression ISO RGD:1312404 6480464 Chlorpyrifos results in decreased expression of TRAF3IP2 mRNA CTD PMID:37019170 Traf3ip2 Rat ciglitazone multiple interactions ISO RGD:1312403 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of TRAF3IP2 mRNA CTD PMID:16197558 Traf3ip2 Rat cisplatin multiple interactions ISO RGD:1312403 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA CTD PMID:21858171 Traf3ip2 Rat cisplatin increases expression ISO RGD:1312403 6480464 Cisplatin results in increased expression of TRAF3IP2 mRNA CTD PMID:27392435 Traf3ip2 Rat cisplatin affects expression ISO RGD:1312403 6480464 Cisplatin affects the expression of TRAF3IP2 mRNA CTD PMID:23300844 Traf3ip2 Rat copper(II) sulfate decreases expression ISO RGD:1312403 6480464 Copper Sulfate results in decreased expression of TRAF3IP2 mRNA CTD PMID:19549813 Traf3ip2 Rat cyclosporin A increases expression ISO RGD:1312403 6480464 Cyclosporine results in increased expression of TRAF3IP2 mRNA CTD PMID:25562108 Traf3ip2 Rat diarsenic trioxide increases expression ISO RGD:1312403 6480464 Arsenic Trioxide results in increased expression of TRAF3IP2 mRNA CTD PMID:15761015 Traf3ip2 Rat diiodine multiple interactions ISO RGD:1312404 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRAF3IP2 mRNA CTD PMID:36706583 Traf3ip2 Rat dorsomorphin multiple interactions ISO RGD:1312403 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Traf3ip2 Rat ethanol increases expression ISO RGD:1312404 6480464 Ethanol results in increased expression of TRAF3IP2 mRNA CTD PMID:19167417 Traf3ip2 Rat glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 Traf3ip2 Rat imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 Traf3ip2 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of TRAF3IP2 mRNA CTD PMID:21396975 Traf3ip2 Rat lead(0) decreases expression ISO RGD:1312403 6480464 Lead results in decreased expression of TRAF3IP2 mRNA CTD PMID:19921347 Traf3ip2 Rat lipopolysaccharide increases expression ISO RGD:1312403 6480464 Lipopolysaccharides results in increased expression of TRAF3IP2 mRNA CTD PMID:31059760|PMID:35811015 Traf3ip2 Rat lipopolysaccharide multiple interactions ISO RGD:1312403 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRAF3IP2 mRNA CTD PMID:35811015 Traf3ip2 Rat maneb multiple interactions ISO RGD:1312404 6480464 [Maneb co-treated with Paraquat] results in increased expression of ACT1 protein CTD PMID:23562983 Traf3ip2 Rat menadione affects expression ISO RGD:1312403 6480464 Vitamin K 3 affects the expression of TRAF3IP2 mRNA CTD PMID:20044591 Traf3ip2 Rat monosodium L-glutamate decreases expression ISO RGD:1312404 6480464 Sodium Glutamate results in decreased expression of TRAF3IP2 mRNA CTD PMID:22078008 Traf3ip2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TRAF3IP2 mRNA CTD PMID:25729387 Traf3ip2 Rat ozone multiple interactions ISO RGD:1312403 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ... CTD PMID:32699268 Traf3ip2 Rat paracetamol decreases expression ISO RGD:1312403 6480464 Acetaminophen results in decreased expression of TRAF3IP2 mRNA CTD PMID:21420995 Traf3ip2 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of TRAF3IP2 mRNA CTD PMID:33387578 Traf3ip2 Rat paraquat multiple interactions ISO RGD:1312404 6480464 [Maneb co-treated with Paraquat] results in increased expression of ACT1 protein CTD PMID:23562983 Traf3ip2 Rat pirinixic acid multiple interactions ISO RGD:1312403 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Traf3ip2 Rat pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of TRAF3IP2 mRNA CTD PMID:19162173 Traf3ip2 Rat pirinixic acid decreases expression ISO RGD:1312404 6480464 pirinixic acid results in decreased expression of TRAF3IP2 mRNA CTD PMID:17426115 Traf3ip2 Rat piroxicam multiple interactions ISO RGD:1312403 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA CTD PMID:21858171 Traf3ip2 Rat poly(I:C) multiple interactions ISO RGD:1312403 6480464 [TL8-506 co-treated with Poly I-C] results in increased expression of TRAF3IP2 mRNA CTD PMID:35688559 Traf3ip2 Rat potassium chromate decreases expression ISO RGD:1312403 6480464 potassium chromate(VI) results in decreased expression of TRAF3IP2 mRNA CTD PMID:22079256 Traf3ip2 Rat potassium chromate multiple interactions ISO RGD:1312403 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRAF3IP2 mRNA CTD PMID:22079256 Traf3ip2 Rat raloxifene multiple interactions ISO RGD:1312403 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of TRAF3IP2 mRNA CTD PMID:19059307 Traf3ip2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1312403 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRAF3IP2 mRNA CTD PMID:35811015 Traf3ip2 Rat SB 431542 multiple interactions ISO RGD:1312403 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Traf3ip2 Rat silicon dioxide increases expression ISO RGD:1312403 6480464 Silicon Dioxide analog results in increased expression of TRAF3IP2 mRNA CTD PMID:23806026 Traf3ip2 Rat sodium arsenite decreases expression ISO RGD:1312403 6480464 sodium arsenite results in decreased expression of TRAF3IP2 mRNA CTD PMID:38568856 Traf3ip2 Rat sodium arsenite multiple interactions ISO RGD:1312403 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRAF3IP2 more ... CTD PMID:39836092 Traf3ip2 Rat sodium fluoride increases expression ISO RGD:1312404 6480464 Sodium Fluoride results in increased expression of TRAF3IP2 mRNA; Sodium Fluoride results in increased expression more ... CTD PMID:30225638 Traf3ip2 Rat sunitinib decreases expression ISO RGD:1312403 6480464 Sunitinib results in decreased expression of TRAF3IP2 mRNA CTD PMID:31533062 Traf3ip2 Rat tamoxifen multiple interactions ISO RGD:1312403 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of TRAF3IP2 mRNA CTD PMID:19059307 Traf3ip2 Rat thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... CTD PMID:33854195 Traf3ip2 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of TRAF3IP2 mRNA CTD PMID:34492290 Traf3ip2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of TRAF3IP2 mRNA CTD PMID:25729387 Traf3ip2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of TRAF3IP2 mRNA CTD PMID:33387578 Traf3ip2 Rat triphenyl phosphate affects expression ISO RGD:1312403 6480464 triphenyl phosphate affects the expression of TRAF3IP2 mRNA CTD PMID:37042841 Traf3ip2 Rat valproic acid increases methylation ISO RGD:1312403 6480464 Valproic Acid results in increased methylation of TRAF3IP2 gene CTD PMID:29154799 Traf3ip2 Rat valproic acid increases expression ISO RGD:1312403 6480464 Valproic Acid results in increased expression of TRAF3IP2 mRNA CTD PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799 Traf3ip2 Rat valproic acid multiple interactions ISO RGD:1312403 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386